In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
Dalia Blass this month will wrap up her more than three-year tenure as director of the Securities and Exchange Commission's Division of Investment Management, a time ...
Regulatory matters are expected to take up a sizable chunk of time on mutual fund boards' 2021 agendas. The new rule on fair valuation practices is ...
The Securities and Exchange Commission on Thursday adopted a new rule on fund valuation practices, the first comprehensive update in 50 years. Rule 2a-5 will permit ...
It's a good thing Carolyn McPhillips had the experience she did when she took the helm at Mutual Fund Directors Forum last June because she had ...